| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/24/2002 | CA2359606A1 Cysteine/glycine rich peptides |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376654 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 04/23/2002 | US6376653 Tie2 antagonist antibodies |
| 04/23/2002 | US6376651 Amino acid sequences of a caf 1-related protein and to the use of these sequences in the diagnosis, treatment, and prevention of disorders associated with cell proliferation and inflammation. |
| 04/23/2002 | US6376529 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376518 Anticarcinogenic agents; side effect reduction |
| 04/23/2002 | US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases |
| 04/23/2002 | US6376498 Pharmaceutical, cosmetic and/or food composition with antioxidant properties |
| 04/23/2002 | US6376496 Inhibitors of prenyl-protein transferase |
| 04/23/2002 | US6376493 Selective inhibition of phosphodiesterase iv and tumor necrosis factor; useful in treating osteoporosis, tumors, autoimmune diseases, rheumatic diseases, and asthma |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376480 Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 04/23/2002 | US6376470 Cytosine arabinose, cytarabine, 1-(beta-d-arabinofuranosyl) cytosine nucleotide analog anticancer for acute myelogenous leukemia and some non-solid tumors; ara-c residues are only found on the termini of the polyethylene glycol polymer |
| 04/23/2002 | US6376468 Protein:prenyl transferase inhibitors |
| 04/23/2002 | US6376224 Composition comprising inhibitor for membrane pumps and photoaffinity-labeled chemotherapeutic agent |
| 04/23/2002 | US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 04/23/2002 | US6375953 Treatment of infectious diseases with HSP70-peptide complexes |
| 04/23/2002 | US6375945 Qs-21 and qs-17, 3-o-deacylated monophosphoryl lipid a and interleukin 12, where qs-21 and qs-17 are derived from the bark of the south american tree quillaja saponaria molina |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/23/2002 | CA2263353C Arylsulfonylimidazolone derivatives as an antitumor agent |
| 04/23/2002 | CA2067395C Antimetastatically acting agents |
| 04/18/2002 | WO2002031511A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 04/18/2002 | WO2002031498A2 Protecting therapeutic compositions from host-mediated inactivation |
| 04/18/2002 | WO2002031201A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/18/2002 | WO2002031198A2 Cancer-linked genes as targets for chemotherapy |
| 04/18/2002 | WO2002031151A2 Lipocalins |
| 04/18/2002 | WO2002031145A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/18/2002 | WO2002031142A2 Antisense nucleic acid against alphav integrin |
| 04/18/2002 | WO2002031134A2 Novel serine protease genes related to dppiv |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002030986A2 HUMANIZED ANTI-LT-β-R ANTIBODIES |
| 04/18/2002 | WO2002030982A2 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use |
| 04/18/2002 | WO2002030970A2 Human histone deacetylase gene |
| 04/18/2002 | WO2002030942A2 Anhydro sugar derivatives of indolocarbazoles |
| 04/18/2002 | WO2002030941A2 Topoisomerase inhibitors |
| 04/18/2002 | WO2002030932A2 N8,n13-disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents |
| 04/18/2002 | WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 04/18/2002 | WO2002030926A1 Quinazoline derivatives |
| 04/18/2002 | WO2002030924A1 Quinazoline derivatives with anti-tumour activity |
| 04/18/2002 | WO2002030922A2 Dioxolane analogs for improved inter-cellular delivery |
| 04/18/2002 | WO2002030910A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/18/2002 | WO2002030906A1 Anti-tumour compounds |
| 04/18/2002 | WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS |
| 04/18/2002 | WO2002030894A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030886A2 Heterocyclic angiogenesis inhibitors |
| 04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030882A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030879A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 04/18/2002 | WO2002030866A1 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 04/18/2002 | WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030470A1 Methods and compositions for nucleic acid delivery |
| 04/18/2002 | WO2002030465A2 Compositions that inhibit proliferation of cancer cells |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030458A1 Yersinia adhesion protein as vaccine adjuvant |
| 04/18/2002 | WO2002030455A2 Agents for the treatment of viral infections |
| 04/18/2002 | WO2002030453A1 Methods of inhibiting angiogenesis using nadph oxidase inhibitors |
| 04/18/2002 | WO2002030441A2 Treatment of cancers by aplidine in conjunction with a myoprotector |
| 04/18/2002 | WO2002030438A1 Anticancer composition comprising sesquiterpenes isolated from resina ferulae |
| 04/18/2002 | WO2002030434A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 04/18/2002 | WO2002030433A2 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 04/18/2002 | WO2002030429A1 Combination therapy for the treatment of estrogen-sensitive disease |
| 04/18/2002 | WO2002030424A1 Modified prodrug forms of ap/amp |
| 04/18/2002 | WO2002030423A1 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030422A1 Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma |
| 04/18/2002 | WO2002030407A1 ESTROGEN RECEPTOR-β LIGANDS |
| 04/18/2002 | WO2002030397A1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 04/18/2002 | WO2002030393A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 04/18/2002 | WO2002030356A2 Synthesis of epothilones and relates analogs |
| 04/18/2002 | WO2002030353A2 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030268A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | WO2002017968A3 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain-2 |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002014499A9 Claudin polypeptides |
| 04/18/2002 | WO2002012210A9 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 04/18/2002 | WO2002011742A3 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 04/18/2002 | WO2002011740A3 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 04/18/2002 | WO2002011668A3 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients |
| 04/18/2002 | WO2002009679A3 Use of 13-cis retinoic acid for the treatment of emphysema |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/18/2002 | WO2002000624A3 Methods and compounds for inhibiting mrp1 |
| 04/18/2002 | WO2001087272A3 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 04/18/2002 | WO2001087265A3 Pharmaceutical form of administration for peptides, methods for its production and use |
| 04/18/2002 | WO2001085715A3 Aza- and polyazanthranyl amides and their use as medicaments |
| 04/18/2002 | WO2001082969A3 Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent |
| 04/18/2002 | WO2001082958A3 Methods of producing membrane vesicles |
| 04/18/2002 | WO2001082952A3 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS |
| 04/18/2002 | WO2001081579A8 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis |
| 04/18/2002 | WO2001080807A3 Medicine containing polysaccharide substances for activating apoptosis |
| 04/18/2002 | WO2001079436A3 A novel polypeptide - human cell differentiation transcription factor 10 and the polynucleotide encoding said polypeptide |
| 04/18/2002 | WO2001077287A3 A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide |
| 04/18/2002 | WO2001075055A3 A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide |